id	domain	url
amwa-224	www.amwajournal.org	http://www.amwajournal.org
amwa-224	www.amwajournal.org	http://www.amwajournal.org
amwa-224	www.amwajournal.org	http://www.amwajournal.org
amwa-224	www.amwajournal.org	http://www.amwajournal.org
amwa-224	www.amwajournal.org	http://www.amwajournal.org
amwa-224	www.adcetrispro.com	https://www.adcetrispro.com
amwa-224	besponsa.pfizerpro.com	https://besponsa.pfizerpro.com
amwa-224	gskpro.com	https://gskpro.com/content
amwa-224	mylotarg.pfizerpro.com	https://mylotarg.pfizerpro.com
amwa-224	www.polivy.com	https://www.polivy.com/hcp.html
amwa-224	www.enhertuhcp.com	https://www.enhertuhcp.com
amwa-224	www.kadcyla-hcp.com	https://www.kadcyla-hcp.com
amwa-224	www.padcev.com	https://www.padcev.com/hcp
amwa-224	www.tivdakhcp.com	https://www.tivdakhcp.com
amwa-224	www.trodelvyhcp.com	https://www.trodelvyhcp.com
amwa-224	www.amwajournal.org	http://www.amwajournal.org
amwa-224	www.adcetrispro.com	https://www.adcetrispro.com
amwa-224	besponsa.pfizerpro.com	https://besponsa.pfizerpro.com
amwa-224	gskpro.com	https://gskpro.com/content/dam/global/hcpportal/en_us/prescribing_information/blenrep/pdf/blenrep-pi-mg.pdf
amwa-224	gskpro.com	https://gskpro.com/content/dam/global/hcpportal/en_us/prescribing_information/blenrep/pdf/blenrep-pi-mg.pdf
amwa-224	gskpro.com	https://gskpro.com/content/dam/global/hcpportal/en_us/prescribing_information/blenrep/pdf/blenrep-pi-mg.pdf
amwa-224	www.lumoxiti.com	https://www.lumoxiti.com
amwa-224	www.lumoxiti.com	https://www.lumoxiti.com
amwa-224	mylotarg.pfizerpro.com	https://mylotarg.pfizerpro.com
amwa-224	www.polivy.com	https://www.polivy.com/hcp.html
amwa-224	www.zynlontahcp.com	https://www.zynlontahcp.com
amwa-224	www.zynlontahcp.com	https://www.zynlontahcp.com
amwa-224	www.immunogen.com	https://www.immunogen.com/wp-content/uploads/2022/11/elahere_pi.pdf
amwa-224	www.immunogen.com	https://www.immunogen.com/wp-content/uploads/2022/11/elahere_pi.pdf
amwa-224	www.enhertuhcp.com	https://www.enhertuhcp.com/en/breast
amwa-224	www.enhertuhcp.com	https://www.enhertuhcp.com/en/breast
amwa-224	www.kadcyla-hcp.com	https://www.kadcyla-hcp.com
amwa-224	www.padcev.com	https://www.padcev.com/hcp
amwa-224	www.tivdakhcp.com	https://www.tivdakhcp.com
amwa-224	www.trodelvyhcp.com	https://www.trodelvyhcp.com
amwa-224	www.amwajournal.org	http://www.amwajournal.org
amwa-224	www.biochempeg.com	https://www.biochempeg.com/article/74.html
amwa-224	www.destinyclinicaltrials.com	https://www.destinyclinicaltrials.com/en
amwa-224	www.fda.gov	https://www.fda.gov
amwa-224	www.fda.gov	https://www.fda.gov/drugs/resources-informationapproved-drugs/fda-approves-fam-trastuzumab-deruxtecannxki-her2-positive-gastric-adenocarcinomas
amwa-224	www.fda.gov	https://www.fda.gov/drugs
amwa-224	www.fda.gov	https://www.fda.gov
amwa-224	cen.acs.org	https://cen.acs.org/pharmaceuticals/biologics/new-dayantibody-drug-conjugates/100/i17
amwa-224	www.amwa.org	www.amwa.org/online_learning
amwa-224	www.amwajournal.org	http://www.amwajournal.org
amwa-224	www.personalizedmedicinecoalition.org	http://www.personalizedmedicinecoalition.org/userfiles/pmc-corporate/file/the_evolution_of_biomarker_use_in_clinical_trials_for_cancer_treatments.pdf
amwa-224	www.personalizedmedicinecoalition.org	http://www.personalizedmedicinecoalition.org/userfiles/pmc-corporate/file/the_evolution_of_biomarker_use_in_clinical_trials_for_cancer_treatments.pdf
amwa-224	www.personalizedmedicinecoalition.org	http://www.personalizedmedicinecoalition.org/userfiles/pmc-corporate/file/the_evolution_of_biomarker_use_in_clinical_trials_for_cancer_treatments.pdf
amwa-224	www.biochempeg.com	https://www.biochempeg.com/article/74.html
amwa-224	www.destinyclinicaltrials.com	https://www.destinyclinicaltrials.com/en
amwa-224	www.fda.gov	https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-regular-approval-fam-trastuzumab-deruxtecan-nxki-breast-cancer
amwa-224	www.fda.gov	https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-regular-approval-fam-trastuzumab-deruxtecan-nxki-breast-cancer
amwa-224	www.fda.gov	https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-regular-approval-fam-trastuzumab-deruxtecan-nxki-breast-cancer
amwa-224	www.fda.gov	https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-fam-trastuzumab-deruxtecan-nxki-her2-positive-gastric-adenocarcinomas
amwa-224	www.fda.gov	https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-fam-trastuzumab-deruxtecan-nxki-her2-positive-gastric-adenocarcinomas
amwa-224	www.fda.gov	https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-fam-trastuzumab-deruxtecan-nxki-her2-positive-gastric-adenocarcinomas
amwa-224	www.fda.gov	https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-accelerated-approval-fam-trastuzumab-deruxtecan-nxki-her2-mutant-non-small-cell-lung
amwa-224	www.fda.gov	https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-accelerated-approval-fam-trastuzumab-deruxtecan-nxki-her2-mutant-non-small-cell-lung
amwa-224	www.fda.gov	https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-accelerated-approval-fam-trastuzumab-deruxtecan-nxki-her2-mutant-non-small-cell-lung
amwa-224	www.fda.gov	https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-accelerated-approval-fam-trastuzumab-deruxtecan-nxki-her2-mutant-non-small-cell-lung
amwa-224	www.fda.gov	https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-fam-trastuzumab-deruxtecan-nxki-her2-low-breast-cancer
amwa-224	www.fda.gov	https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-fam-trastuzumab-deruxtecan-nxki-her2-low-breast-cancer
amwa-224	www.fda.gov	https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-fam-trastuzumab-deruxtecan-nxki-her2-low-breast-cancer
amwa-224	cen.acs.org	https://cen.acs.org/pharmaceuticals/biologics/new-day-antibody-drug-conjugates/100/i17
amwa-224	cen.acs.org	https://cen.acs.org/pharmaceuticals/biologics/new-day-antibody-drug-conjugates/100/i17